Thomas Dörner, MD - B-Cell Depletion for Autoimmune Rheumatic Diseases: Expert Perspectives of This Mechanistic Therapeutic Approach in Clinical Context

What this episode covers

Visit https://www.peervoice.com/SDS860 to view the entire programme with slides. After completing “Thomas Dörner, MD - B-Cell Depletion for Autoimmune Rheumatic Diseases: Expert Perspectives of This Mechanistic Therapeutic Approach in Clinical Context”, participants will be able to: Explain the impact of suboptimal treatment of autoimmune rheumatic diseases on patient outcomes; Discuss the mechanistic role of B cells in the pathophysiology of autoimmune rheumatic diseases; Explain why—despite suboptimal results with established B-cell–targeting therapies in autoimmune rheumatic diseases such as Sjögren’s disease, systemic lupus erythematosus (SLE), and lupus nephritis—B-cell–targeting still holds therapeutic promise; and Identify B-cell–targeting therapies currently being investigated for autoimmune rheumatic diseases and their methods for achieving B-cell depletion.

Distinct summary based on available episode metadata or transcript content.